FY2027UpcomingSelected edition
Effective from
- Inherited rules changed
Activated Phosphoinositide 3-kinase Delta Syndrome [APDS]
Billable diagnosis code
CDC/NCHS · FY2027autosomal recessive agammaglobulinemia (Swiss type) (D80.0)
human immunodeficiency virus [HIV] disease (B20)
Coverage depends on the payer, service and applicable policy. A billable code does not guarantee payment.
For US diagnosis claims covered by HIPAA, ICD-10-CM is required from October 1, 2015.
Use the service date for outpatient/professional claims and the discharge date for hospital inpatient claims. Earlier encounters use ICD-9-CM; each individual code must also be valid for the applicable date.
Official coding guidelines → · CMS ↗First observed · 2022-10-01
Latest recorded change · FY2027
Effective from
Activated Phosphoinositide 3-kinase Delta Syndrome [APDS]
Billable diagnosis code
CDC/NCHS · FY2027| All editions | Effective from | Code history |
|---|---|---|
| FY2023 | 2022-10-01 | Added |
| FY2023 · 04-01 | 2023-04-01 | No tabular change |
| FY2024 | 2023-10-01 | No tabular change |
| FY2024 · 04-01 | 2024-04-01 | No tabular change |
| FY2025 | 2024-10-01 | No tabular change |
| FY2025 · 04-01 | 2025-04-01 | No tabular change |
| FY2026 | 2025-10-01 | Inherited rules changed |
| FY2026 · April | 2026-04-01 | No tabular change |
| FY2027 | 2026-10-01 | Inherited rules changed |
p110d-activating mutation causing senescent T cells, lymphadenopathy, and immunodeficiency [PASLI] disease
human immunodeficiency virus [HIV] disease (B20)
autosomal recessive agammaglobulinemia (Swiss type) (D80.0)
Historical assignments from the CDC conversion table support data retrieval. They do not authorize substituting a previous code for the current code.
Previous assignment: D81.89
Other entries in the same category; these are not automatic substitutes.
| Code | Description | Category · further specificity required |
|---|---|---|
| D81.81 | Biotin-dependent carboxylase deficiency | Category · further specificity required |
| D81.89 | Other combined immunodeficiencies | Billable / specific |
Official titles and instructions are preserved in their source language. Official sources ↗